Wockhardt Limited has informed the Exchange regarding a press release dated May 29, 2025, titled "Press Release on the Audited Financial Results (Standalone and Consolidated) for the quarter and the financial year ended 31st March, 2025".
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Limited has informed the stock exchange about a press release dated May 29, 2025, containing its audited financial results for the fourth quarter and full financial year ended March 31, 2025. The filing covers both standalone and consolidated financial performance. This is a regulatory disclosure notifying the exchange that the detailed results are available in the attached press release. No specific revenue, profit, or margin figures are included in this filing itself — investors would need to refer to the attached press release or the company's results PDF for the actual numbers.
This is a routine compliance filing under listing rules and does not by itself move the stock. The actual market reaction will depend on the numbers in the press release, particularly growth in key segments like the India business, US generics, and the impact of remediation efforts at its facilities.